Compare Stocks: CIF, PAI, SAGU, and BRBI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BRBI BR Biopharma	$9.13 -2.9%	$11.27	$9.13 ▼ $67.01	$111.01M	N/A	467 shs	241 shs
CIF MFS Intermediate High Income Fund	$1.60	$1.61	$1.57 ▼ $1.82	$28.64M	0.71	77,609 shs	63,396 shs
PAI Western Asset Investment Grade Income Fund	$11.94 -0.2%	$12.04	$11.72 ▼ $13.01	$113.75M	0.49	14,915 shs	6,067 shs
SAGU Shreya Acquisition Group	$9.96 +0.2%	$9.92	$9.85 ▼ $10.05	$111.64M	N/A	7,158 shs	11,620 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BRBI BR Biopharma	0.00%	-9.79%	-18.29%	-30.73%	+939,999,900.00%
CIF MFS Intermediate High Income Fund	0.00%	0.00%	0.00%	-0.62%	-8.31%
PAI Western Asset Investment Grade Income Fund	0.00%	0.00%	-0.87%	-1.12%	-5.90%
SAGU Shreya Acquisition Group	0.00%	+0.15%	+0.26%	+995,499,900.00%	+995,499,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BRBI BR Biopharma	$9.13 -2.9%	$11.27	$9.13 ▼ $67.01	$111.01M	N/A	467 shs	241 shs
CIF MFS Intermediate High Income Fund	$1.60	$1.61	$1.57 ▼ $1.82	$28.64M	0.71	77,609 shs	63,396 shs
PAI Western Asset Investment Grade Income Fund	$11.94 -0.2%	$12.04	$11.72 ▼ $13.01	$113.75M	0.49	14,915 shs	6,067 shs
SAGU Shreya Acquisition Group	$9.96 +0.2%	$9.92	$9.85 ▼ $10.05	$111.64M	N/A	7,158 shs	11,620 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BRBI BR Biopharma	0.00%	-9.79%	-18.29%	-30.73%	+939,999,900.00%
CIF MFS Intermediate High Income Fund	0.00%	0.00%	0.00%	-0.62%	-8.31%
PAI Western Asset Investment Grade Income Fund	0.00%	0.00%	-0.87%	-1.12%	-5.90%
SAGU Shreya Acquisition Group	0.00%	+0.15%	+0.26%	+995,499,900.00%	+995,499,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BRBI BR Biopharma	1.00	Sell	N/A	N/A
CIF MFS Intermediate High Income Fund	0.00	N/A	N/A	N/A
PAI Western Asset Investment Grade Income Fund	0.00	N/A	N/A	N/A
SAGU Shreya Acquisition Group	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest CIF, PAI, SAGU, and BRBI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
6/4/2026	BRBI BR Biopharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (D-)
5/22/2026	BRBI BR Biopharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)

(Data available from 8/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BRBI BR Biopharma	$2.23B	0.05	$2.74 per share	3.33	$11.88 per share	0.77
CIF MFS Intermediate High Income Fund	N/A	N/A	N/A	N/A	N/A	N/A
PAI Western Asset Investment Grade Income Fund	N/A	N/A	N/A	N/A	N/A	N/A
SAGU Shreya Acquisition Group	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BRBI BR Biopharma	$31.36M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CIF MFS Intermediate High Income Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PAI Western Asset Investment Grade Income Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SAGU Shreya Acquisition Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest CIF, PAI, SAGU, and BRBI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/6/2026	Q2 2026	BRBI BR Biopharma	N/A	$0.09	N/A	$0.09	N/A	$25.13 million
6/30/2026	Q2 2026	BRBI BR Biopharma	N/A	$0.09	N/A	$0.09	N/A	$25.13 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BRBI BR Biopharma	$0.50	5.48%	N/A	N/A	N/A
CIF MFS Intermediate High Income Fund	$0.17	10.63%	N/A	N/A	N/A
PAI Western Asset Investment Grade Income Fund	$0.63	5.28%	N/A	N/A	N/A
SAGU Shreya Acquisition Group	N/A	N/A	N/A	N/A	N/A

Latest CIF, PAI, SAGU, and BRBI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/7/2026	BRBI BR Biopharma	quarterly	$0.1415	6.2%	8/17/2026	8/17/2026	9/4/2026
5/21/2026	PAI Western Asset Investment Grade Income Fund	monthly	$0.0525	5.26%	8/24/2026	8/24/2026	8/31/2026
5/21/2026	PAI Western Asset Investment Grade Income Fund	monthly	$0.0525	5.31%	7/24/2026	7/24/2026	7/31/2026
5/21/2026	PAI Western Asset Investment Grade Income Fund	monthly	$0.0525	5.22%	6/23/2026	6/23/2026	6/30/2026
5/29/2026	CIF MFS Intermediate High Income Fund	monthly	$0.0141	10.64%	6/8/2026	6/8/2026	6/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BRBI BR Biopharma	N/A	0.87	0.87
CIF MFS Intermediate High Income Fund	N/A	N/A	N/A
PAI Western Asset Investment Grade Income Fund	N/A	N/A	N/A
SAGU Shreya Acquisition Group	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BRBI BR Biopharma	N/A
CIF MFS Intermediate High Income Fund	6.85%
PAI Western Asset Investment Grade Income Fund	18.99%
SAGU Shreya Acquisition Group	N/A

Insider Ownership

Company	Insider Ownership
BRBI BR Biopharma	N/A
CIF MFS Intermediate High Income Fund	N/A
PAI Western Asset Investment Grade Income Fund	1.00%
SAGU Shreya Acquisition Group	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BRBI BR Biopharma	N/A	11.81 million	N/A	N/A
CIF MFS Intermediate High Income Fund	N/A	17.90 million	N/A	Not Optionable
PAI Western Asset Investment Grade Income Fund	204,000	9.51 million	9.42 million	Not Optionable
SAGU Shreya Acquisition Group	N/A	11.23 million	N/A	N/A

CIF, PAI, SAGU, and BRBI Headlines

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

Top Headlines

View All

CIF, PAI, SAGU, and BRBI Company Descriptions

BR Biopharma NASDAQ:BRBI

$9.13 -0.27 (-2.87%)

As of 01:28 PM Eastern

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.

MFS Intermediate High Income Fund NYSE:CIF

MFS Intermediate High Income Fund is a closed ended fixed income mutual fund launched and managed by Massachusetts Financial Services Company. The fund invests in fixed income markets of the United States. It primarily invests in high income debt instruments. The fund benchmarks the performance of its portfolio against Barclays U.S. High-Yield Corporate 2% Issuer Capped Index. It was formerly known as Colonial Intermediate High Income Fund. MFS Intermediate High Income Fund was founded in July 21, 1988 and is domiciled in United States.

Western Asset Investment Grade Income Fund NYSE:PAI

$11.94 -0.02 (-0.17%)

As of 03:03 PM Eastern

Western Asset Income Fund is a closed-ended fixed income mutual fund launched and managed by Western Asset Management Company. It is co-managed by Western Asset Management Company Limited. The fund invests in the fixed income markets of the United States. It primarily invests in investment grade debt, including government securities, bank debt, commercial paper, and cash or cash equivalents. The fund benchmarks the performance of its portfolio against the Barclays U.S. Corporate High Yield Index and the Barclays U.S. Credit Index. Western Asset Income Fund was formed on March 22, 1973 and is domiciled in the United States.

Shreya Acquisition Group NYSE:SAGU

$9.96 +0.02 (+0.15%)

As of 10:13 AM Eastern

Shreya Acquisition Group is a blank check company. It formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. Shreya Acquisition Group is based in NEW YORK.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CIF, PAI, SAGU, and BRBI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CIF, PAI, SAGU, and BRBI Earnings

Compare Dividends

Latest CIF, PAI, SAGU, and BRBI Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CIF, PAI, SAGU, and BRBI Headlines

Recent News About These Companies

Media Sentiment Over Time

Top Headlines

CIF, PAI, SAGU, and BRBI Company Descriptions

BR Biopharma NASDAQ:BRBI

MFS Intermediate High Income Fund NYSE:CIF

Western Asset Investment Grade Income Fund NYSE:PAI

Shreya Acquisition Group NYSE:SAGU

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CIF, PAI, SAGU, and BRBI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CIF, PAI, SAGU, and BRBI Earnings

Compare Dividends

Latest CIF, PAI, SAGU, and BRBI Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CIF, PAI, SAGU, and BRBI Headlines

Recent News About These Companies

Media Sentiment Over Time

Top Headlines

CIF, PAI, SAGU, and BRBI Company Descriptions

BR Biopharma NASDAQ:BRBI

MFS Intermediate High Income Fund NYSE:CIF

Western Asset Investment Grade Income Fund NYSE:PAI

Shreya Acquisition Group NYSE:SAGU

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools